Myeloma, thalidomide and thrombosis

Leukemia and Lymphoma

Volumn 47, Issue 11, 2006, Pages 2273-2275

  Hönemann, Dirk ^a   Prince, H Miles ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTHRACYCLINE; DEXAMETHASONE; DOXORUBICIN; ENOXAPARIN; LENALIDOMIDE; LOW MOLECULAR WEIGHT HEPARIN; MELPHALAN; PREDNISOLONE; PREDNISONE; STEROID; THALIDOMIDE; WARFARIN;

ANTICOAGULATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLEEDING; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; MONOTHERAPY; MULTIPLE MYELOMA; NOTE; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; THROMBOSIS; VENOUS THROMBOEMBOLISM;

HUMANS; MULTIPLE MYELOMA; THALIDOMIDE; THROMBOSIS;

EID: 33751074915     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600908562     Document Type: Note

References (14)

1. Singhal, S and Mehta, J and Desikan, R and (1999) Antitumor activity of thalidomide in refractory multiple myeloma N Engl J Med, 341, pp. 1565-1571.
2. Rajkumar, S and Blood, E and Vesole, D and Fonseca, R and Greipp, P. (2006) Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: A clinical trial coordinated by the Eastern Cooperative Oncology Group J Clin Oncol, 24, pp. 431-436.
3. Barlogie, B and Tricot, G and Anaissie, E and (2006) Thalidomide and hematopoietic-cell transplantation for multiple myeloma N Engl J Med, 354, pp. 1021-1030.
4. Palumbo, A and Bringhen, S and Caravita, T and (2006) Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: Randomised controlled trial Lancet, 367, pp. 825-831.
5. Glasmacher, A and Hahn, C and Hoffmann, F and (2006) A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma Br J Haematol, 132, pp. 584-593.
6. Zangari, M and Barlogie, B and Anaissie, E and (2004) Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: Effects of prophylactic and therapeutic anticoagulation Br J Haematol, 126, pp. 715-721.
7. Cavo, M and Zamagni, E and Tosi, P and (2004) First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma Haematologica, 89, pp. 826-831.
8. Baz, R and Li, L and Kottke-Marchant, K and (2005) The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma Mayo Clin Proc, 80, pp. 1568-1574.
9. Rajkumar, S and Blood, E. (2006) Lenalidomide and venous thrombosis in multiple myeloma N Engl J Med, 354, pp. 2079-2080.
10. Miller, C and Padmanabhan, S and Dimicelli, L and Depaolo, D and Landrigan, B and Yu, J and (2006) Prospective evaluation of low-dose warfarin for prevention of thalidomide associated venous thromboembolism Leuk Lymph, 47(11), pp. 2339-2343.
11. Minnema, M and Breitkreutz, I and Auwerda, J and (2004) Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy Leukemia, 18, pp. 2044-2046.
12. Ikhlaque, N and Seshadri, V and Kathula, S and Baumann, M. (2006) Efficacy of prophylactic warfarin for prevention of thalidomide-related deep venous thrombosis Am J Hematol, 81, pp. 420-422.
13. Weber, D and Rankin, K and Gavino, M and Delasalle, K and Alexanian, R. (2003) Thalidomide alone or with dexamethasone for previously untreated multiple myeloma J Clin Oncol, 21, pp. 16-19.
14. Osman, K and Comenzo, R and Rajkumar, S. (2001) Deep venous thrombosis and thalidomide therapy for multiple myeloma N Engl J Med, 344, pp. 1951-1952.